ADIPOQ and hyperinsulinism: It also showed decreased insulin resistance through increased adiponectin production and increasing PPARγ expression, while other studies, especially in humans, showed no effect on lipid profile or glycemic status [39, 40] despite moderate hyperinsulinemia.